首页 | 本学科首页   官方微博 | 高级检索  
     

CD4+CD25+ 调节性T 细胞与炎症性肠病
引用本文:柳堤郑萍. CD4+CD25+ 调节性T 细胞与炎症性肠病[J]. 现代生物医学进展, 2012, 12(4): 726-728
作者姓名:柳堤郑萍
作者单位:上海交通大学附属第一人民医院消化科 上海200080
基金项目:上海市教委科研创新项目(No. 10YZ240);上海市教委" 晨光计划" 项目(No. 10CGB03);
摘    要:CD4+CD25+调节性T细胞(Treg)是一种有免疫抑制功能的T淋巴细胞,其在炎症性肠病(IBD)中的功能机制已成为近年免疫学和临床研究的热点。目前,Treg细胞新的表型和作用机制逐渐被大量的实验和研究证实。本文就Treg在IBD发病过程中的作用机理及益生菌对Treg功能的影响做一综述。

关 键 词:炎症性肠病  调节性T细胞  免疫  益生菌

CD4+CD25+ Regulatory T Cells and Inflammatory Bowel Disease
LIU Di,ZHENG Ping. CD4+CD25+ Regulatory T Cells and Inflammatory Bowel Disease[J]. Progress in Modern Biomedicine, 2012, 12(4): 726-728
Authors:LIU Di  ZHENG Ping
Affiliation:(Department of Gastroenterology,The First People’s Hospital,Shanghai Jiaotong University,200080,Shanghai,China)
Abstract:CD4+CD25+ regulatory T cells(Treg) are a T cell lineage capable of suppressing immune response.Its mechanism has become a hotspot in recent immunological and clinical researches.Nowadays,new cell phenotypes and mechanisms has been confirmed through massive experiments and researches.This review focused on the mechanism of Treg in the progress of IBD and the influence of probiotics have on the function of Treg.
Keywords:Inflammatory bowel disease  Regulatory T cells  Immunological  Probiotics
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号